Taxes on Income (Tables)

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Schedule of significant components of deferred tax assets and liabilities

	December 31
	2019			2018
Deferred tax assets:
Carryforward tax losses	$	10,369		$	10,096
Research and development credit		2,716			2,032
Accrued social benefits and other		425			472
		13,510			12,600
Less - valuation allowance		(13,510	)		(12,600	)
Net deferred tax assets	$	-		$	-

Schedule of components of income (loss) before income taxes

	Year ended December 31,
	2019			2018			2017
Domestic	$	(7,107	)	$	(2,372	)	$	4,751
Foreign		444			20			(1,767	)
Income (loss) before income taxes	$	(6,663	)	$	(2,352	)	$	2,984

Schedule of reconciliation of theoretical tax benefit and actual tax expense

	Year ended December 31,
	2019			2018			2017
Income (loss) before income taxes, as reported in the statements of operations	$	(6,663	)	$	(2,352	)	$	2,984
Statutory tax rate in Israel		23	%		23	%		24	%
Theoretical tax benefit	$	(1,532	)	$	(541	)	$	716
Increase (decrease) in income taxes resulting from:
Tax rate differential on foreign subsidiaries		12			(55	)		(166	)
Non-deductible expenses and other permanent differences		473			446			987
Differences in taxes arising from foreign currency exchange, net		42			208			(856	)
Changes in carry forward tax losses and other temporary differences for which valuation allowance was provided		910			(20	)		(554	)
Withholding taxes that were deducted by the Company's customers		-			10			32
Other		264			15			(76	)
Income taxes	$	169		$	63		$	83